About
Lenalidomide is an immunomodulatory drug with a complex mechanism of action encompassing anti-angiogenic, anti-neoplastic, and immunomodulatory properties. As a thalidomide analogue, it exerts direct tumoricidal effects, inhibits the formation of new blood vessels that feed tumors, and enhances the host's anti-tumor immune response by modulating cytokine production and T-cell activation. It is a cornerstone in the treatment of several hematologic malignancies, including multiple myeloma, myelodysplastic syndromes (MDS) with a del(5q) cytogenetic abnormality, and mantle cell lymphoma. Due to its potent teratogenic effects, lenalidomide is subject to stringent risk management programs to prevent fetal exposure. Its multifaceted actions have significantly improved response rates and survival outcomes for patients suffering from these challenging conditions, often used in combination with other therapeutic agents.
Uses
- Multiple Myeloma
- Myelodysplastic Syndromes (del(5q))
- Mantle Cell Lymphoma
- Follicular Lymphoma (in combination)
Directions For Use
Take orally once daily with or without food, as prescribed. Swallow capsules whole.
Benefits
- Effective in multiple myeloma
- Improves cytogenetic response in MDS del(5q)
- Induces tumor regression in lymphoma
- Modulates immune response
- Inhibits angiogenesis
- Often used in combination therapies
Side Effects
- Myelosuppression (neutropenia, thrombocytopenia)
- Deep vein thrombosis (DVT)
- Pulmonary embolism (PE)
- Fatigue
- Diarrhea
- Rash
- Peripheral neuropathy
- Muscle cramps
- Nausea
- Constipation
- Dizziness
- Hypothyroidism
Safety Measures
- Alcohol - No specific interaction, but avoid excessive alcohol due to potential for exacerbating fatigue or liver stress.
- Pregnancy - Absolutely contraindicated due to severe teratogenic effects; strict contraception is mandatory for both males and females.
- Breastfeeding - Not recommended; discontinue breastfeeding during treatment due to potential harm to the infant.
- Liver - Use with caution in patients with hepatic impairment; dose adjustments may be necessary.
- Kidney - Dose reduction is required in patients with renal impairment due to significant renal excretion.
- Lung - Monitor for pulmonary symptoms; interstitial lung disease and pulmonary hypertension have been reported.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!